Is a complete AIM research report available?

No complete published report is available for AIM ImmunoTech Inc. (AIM) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

AIM ImmunoTech Inc. (AIM)

NYSEAMERICAN: AIM · USD

$0.17

+0.00 (+1.0%)· Recorded snapshot

Market cap	5.1M
Revenue (ttm)	95K
Net income (ttm)	-14.3M
EPS (ttm)	-$2.14
Shares out	30.4M
Volume	165,930
Beta	1.27

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 95K
Net income (ttm): -14.3M
EPS (ttm): -$2.14
Market cap: 5.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	نگه‌داری

Metric	Value
Amount currency	USD
CIK code	0000946644
Company name	AIM ImmunoTech Inc.
Country	United States
Country code	US
CUSIP number	00901B303
Earnings date	2026-11-09
Earnings time	amc
Employees	21
Employees change	-2
Employees growth	-8.7%
Enterprise value	$-934,809
Exchange	NYSEAMERICAN
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1966
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US00901B3033
Last 10-K release date	2026-03-27
Last earnings date	2026-08-10
Last refreshed	2026-10-28
Last stock split date	2026-01-09
Last stock split type	Forward
Market cap	$5.1M
Market cap category	Nano-Cap
Next earnings date	2026-11-09
Options	No
Price	$0.17
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	AIM
U.S. state	Florida
Website	https://aimimmuno.com

Metric

Value

Amount currency

USD

CIK code

0000946644

Company name

AIM ImmunoTech Inc.

Country

United States

Country code

CUSIP number

00901B303

Earnings date

2026-11-09

Earnings time

amc

Employees

Employees change

-2

Employees growth

-8.7%

Enterprise value

$-934,809

Exchange

NYSEAMERICAN

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1966

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US00901B3033

Last 10-K release date

2026-03-27

Last earnings date

2026-08-10

Last refreshed

2026-10-28

Last stock split date

2026-01-09

Last stock split type

Forward

Market cap

$5.1M

Market cap category

Nano-Cap

Next earnings date

2026-11-09

Options

Price

$0.17

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

AIM

U.S. state

Florida

Website

https://aimimmuno.com

Metric	Value
Earnings yield	-1,276.42%
FCF / EV yield	1,508.17%
FCF yield	-282.4%
P/B ratio	0.62x
P/S ratio	53.58x
Price / tangible book value	0.84x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-1,276.42%

FCF / EV yield

1,508.17%

FCF yield

-282.4%

P/B ratio

0.62x

P/S ratio

53.58x

Price / tangible book value

0.84x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Gross margin	-23.16%
Operating margin	-11,724.21%
Pretax margin	-15,021.05%
Profit per employee	$-679,524
Revenue per employee	$4,524
ROA	-82.58%
ROA (5Y)	-59.81%
ROCE	-143.07%
ROE	-2,382.3%
ROIC	-175.7%

Metric

Value

Gross margin

-23.16%

Operating margin

-11,724.21%

Pretax margin

-15,021.05%

Profit per employee

$-679,524

Revenue per employee

$4,524

ROA

-82.58%

ROA (5Y)

-59.81%

ROCE

-143.07%

ROE

-2,382.3%

ROIC

-175.7%

Metric	Value
EPS growth quarters	1
EPS growth years	2
Gross profit growth (Q)	40%
Net income growth years	2
Revenue growth	-21.49%
Revenue growth (Q)	4%
Revenue growth (QoQ)	18.18%
Revenue growth 10Y	-0.9%
Revenue growth 3Y	-17.31%
Revenue growth 5Y	-6.08%
Revenue growth quarters	2
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth (Q)

40%

Net income growth years

Revenue growth

-21.49%

Revenue growth (Q)

Revenue growth (QoQ)

18.18%

Revenue growth 10Y

-0.9%

Revenue growth 3Y

-17.31%

Revenue growth 5Y

-6.08%

Revenue growth quarters

Revenue growth years

Metric	Value
Depreciation and amortization	$404,000
EBIT	$-11.1M
EBITDA	$-10.7M
EPS	$-2.14
FCF per share	$-0.47
Financing cash flow	$23.7M
Free cash flow	$-14.4M
Gross profit	$-22,000
Investing cash flow	$52,000
Net borrowing	$1M
Net cash flow	$9.4M
Net income	$-14.3M
Operating income	$-11.1M
Revenue	$95,000

Metric

Value

Depreciation and amortization

$404,000

EBIT

$-11.1M

EBITDA

$-10.7M

EPS

$-2.14

FCF per share

$-0.47

Financing cash flow

$23.7M

Free cash flow

$-14.4M

Gross profit

$-22,000

Investing cash flow

$52,000

Net borrowing

$1M

Net cash flow

$9.4M

Net income

$-14.3M

Operating income

$-11.1M

Revenue

$95,000

Metric	Value
Altman Z-Score	-50.9
Book value per share	$0.27
Debt / equity	0.51
Interest coverage	-9.52
Long-term assets	$2.3M
Long-term liabilities	$41,000
Net cash (debt)	$6M
Net cash / market cap	118.72%
Net debt / equity	-0.78
Piotroski F-Score	1
Property, plant and equipment	$314,000
Shareholders' equity	$7.7M
Tangible book value	$6M
Tangible book value per share	$0.21
Total assets	$12.7M
Total cash	$10M
Total debt	$3.9M
Total liabilities	$5M
WACC	16.6%

Metric

Value

Altman Z-Score

-50.9

Book value per share

$0.27

Debt / equity

0.51

Interest coverage

-9.52

Long-term assets

$2.3M

Long-term liabilities

$41,000

Net cash (debt)

$6M

Net cash / market cap

118.72%

Net debt / equity

-0.78

Piotroski F-Score

Property, plant and equipment

$314,000

Shareholders' equity

$7.7M

Tangible book value

$6M

Tangible book value per share

$0.21

Total assets

$12.7M

Total cash

$10M

Total debt

$3.9M

Total liabilities

$5M

WACC

16.6%

Metric	Value
Asset turnover	0.01
Current assets	$10.4M
Current liabilities	$4.9M
Current ratio	2.11
Net working capital	$-598,000
Quick ratio	2.01
Working capital	$5.5M
Working capital turnover	-0.05

Metric

Value

Asset turnover

0.01

Current assets

$10.4M

Current liabilities

$4.9M

Current ratio

2.11

Net working capital

$-598,000

Quick ratio

2.01

Working capital

$5.5M

Working capital turnover

-0.05

Metric	Value
Buyback yield / dilution	-894.51%
Dividend yield	0%
Shareholder yield	-894.51%

Metric

Value

Buyback yield / dilution

-894.51%

Dividend yield

Shareholder yield

-894.51%

Metric	Value
150-day SMA	$0.33
1D price change	0.96%
1M price change	-11.73%
1M total return	-11.73%
1W price change	-1.29%
1W total return	-1.29%
1Y price change	-93.39%
1Y return CAGR	-93.4%
1Y total return	-93.39%
20-day SMA	$0.17
200-day SMA	$0.50
3M price change	-32.88%
3M total return	-32.88%
50-day SMA	$0.20
50-day SMA vs 200-day SMA	50under200
52-week high	$2.55
52-week high date	2025-10-28
52-week low	$0.15
52-week low date	2026-10-23
6M price change	-67.46%
6M total return	-67.46%
All-time high	$19.72
All-time high date	2025-07-28
All-time low	$0.15
All-time low date	2026-10-23
Average true range (ATR)	$0.01
Average volume	572.8K
Beta (1Y)	0.2
Beta (2Y)	1.01
Beta (5Y)	1.27
Change from 52-week high	-93.41%
Change from 52-week low	11.64%
Change from all-time high	-99.15%
Change from all-time low	11.64%
Change from open	0.48%
Day's gap	0.48%
Dollar volume	$27,843
High price	$0.17
Low price	$0.17
Monthly RSI	3.4
Open price	$0.17
Position in 52-week range	71.43%
Premarket change	0.42%
Premarket close	$0.17
Premarket price	$0.17
Premarket volume	5.7K
Previous close	$0.17
Price vs 150-day SMA	-49.61%
Price vs 20-day SMA	-2.56%
Price vs 200-day SMA	-66.3%
Price vs 50-day SMA	-17.46%
Relative volume	0.29
RSI	41.48
Sharpe ratio	-0.55
Sortino ratio	-1.08
Volume	165.9K
Weekly RSI	26.01
YTD price change	-84.68%
YTD total return	-84.68%

Metric

Value

150-day SMA

$0.33

1D price change

0.96%

1M price change

-11.73%

1M total return

-11.73%

1W price change

-1.29%

1W total return

-1.29%

1Y price change

-93.39%

1Y return CAGR

-93.4%

1Y total return

-93.39%

20-day SMA

$0.17

200-day SMA

$0.50

3M price change

-32.88%

3M total return

-32.88%

50-day SMA

$0.20

50-day SMA vs 200-day SMA

50under200

52-week high

$2.55

52-week high date

2025-10-28

52-week low

$0.15

52-week low date

2026-10-23

6M price change

-67.46%

6M total return

-67.46%

All-time high

$19.72

All-time high date

2025-07-28

All-time low

$0.15

All-time low date

2026-10-23

Average true range (ATR)

$0.01

Average volume

572.8K

Beta (1Y)

0.2

Beta (2Y)

1.01

Beta (5Y)

1.27

Change from 52-week high

-93.41%

Change from 52-week low

11.64%

Change from all-time high

-99.15%

Change from all-time low

11.64%

Change from open

0.48%

Day's gap

0.48%

Dollar volume

$27,843

High price

$0.17

Low price

$0.17

Monthly RSI

3.4

Open price

$0.17

Position in 52-week range

71.43%

Premarket change

0.42%

Premarket close

$0.17

Premarket price

$0.17

Premarket volume

5.7K

Previous close

$0.17

Price vs 150-day SMA

-49.61%

Price vs 20-day SMA

-2.56%

Price vs 200-day SMA

-66.3%

Price vs 50-day SMA

-17.46%

Relative volume

0.29

RSI

41.48

Sharpe ratio

-0.55

Sortino ratio

-1.08

Volume

165.9K

Weekly RSI

26.01

YTD price change

-84.68%

YTD total return

-84.68%

Metric	Value
Float	27.6M
Float percentage	90.59%
Shares change (QoQ)	293.4%
Shares change (YoY)	894.51%
Shares held by insiders	0.88%
Shares held by institutions	3.77%
Shares outstanding	30.4M
Short % of float	5.1%
Short % of shares	4.62%
Short ratio	0.1 days

Metric

Value

Float

27.6M

Float percentage

90.59%

Shares change (QoQ)

293.4%

Shares change (YoY)

894.51%

Shares held by insiders

0.88%

Shares held by institutions

3.77%

Shares outstanding

30.4M

Short % of float

5.1%

Short % of shares

4.62%

Short ratio

0.1 days

AIM ImmunoTech Inc. (AIM)

Price

Financial snapshot

Fair-value bridge

Latest news · AIM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AIM indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on AIM

Frequently asked questions